Reference
Sani E, et al. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report. Endocrine, Metabolic and Immune Disorders Drug Targets 22: 1053-1057, No. 10, 2022. Available from: URL: http://doi.org/10.2174/1871530322666220509225637
Rights and permissions
About this article
Cite this article
Antihyperglycaemics. Reactions Weekly 1928, 46 (2022). https://doi.org/10.1007/s40278-022-25311-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-25311-0